RECALL Contour PLUS Blood Glucose Test Strips

Awarded Limited / Sole Source Justification Posted

Solicitation number
36C25726F0091
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
36F79724D0097-36C25726F0091 Federal contract award
Place of performance
Dallas, Texas, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs, Veterans Integrated Service Network 17, has awarded a sole-source contract to Ascensia Diabetes Care US Inc. for RECALL Contour PLUS Blood Glucose Test Strips (50-count) and associated system kits under contract 36F79724D0097, with an estimated value of $714,840.

The procurement addresses an FDA-classified Class I Recall affecting glucose monitoring supplies in clinical circulation. The justification cites 41 USC 3304(a)(2), Unusual and Compelling Urgency (RFO 6.103-2), on the grounds that immediate replacement of recalled supplies is necessary to prevent patient harm and ensure continuity of safe diabetic care for veterans. Market research conducted on May 28, 2026 confirmed that Ascensia is the sole manufacturer and OEM of the required products, with no third-party production authorized and no alternative vendors capable of supplying FDA-cleared, recall-compliant items meeting technical and compatibility specifications within the urgent timeframe. The contract operates on a Firm-Fixed Price basis through the mandatory VA National Acquisition Center FSS program. Period of performance runs from June 3, 2026 through July 29, 2027. The anticipated cost is determined fair and reasonable based on negotiated, pre-determined pricing under the NAC FSS program.

Notice text

Please see attached justification for details. 

Awarded contract 36F79724D0097 to unknown vendor for unknown amount on 2026-06-05.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity